CA-KX-SYSTEMS
The SETI Institute announced today that global technology specialist First Derivatives plc (FD) with its Kx technology will provide the analytics capability in partnership with Lockheed Martin and IBM on one of NASA Frontier Development Lab (FDL) research teams this summer.
This year’s FDL teams will tackle three problem areas: planetary defense, space resources and space weather. The Solar Storm team will explore whether AI and sophisticated data processing and tagging tools can be deployed to make a significant breakthrough useful to either defending our planet from Asteroids and Solar Weather or enabling a new frontier of exploration by identifying suitable opportunities for extracting Lunar Water.
“FDL is a new model of innovation that acknowledges the astonishing rate of change in AI related technologies in the private sector” said FDL Director, James Parr. “Our goal is to show that meaningful work, with a high degree of utility to the space program and real world applications that affect all of us, can be done in a very short period of time, by using interdisciplinary techniques and partnering with leaders in AI from the private sector.”
In the era of Big Fast Data analytics, Kx technology has set industry benchmarks for speed and stability in high performance applications, with an ability to handle extreme volumes of historical and streaming data. These attributes are now increasingly recognized across a range of sectors, including Earth Observation, Industrial Internet of Things and MarTech.
Brian Conlon, Chief Executive Officer of FD commented: “Kx is well-suited to using Artificial Intelligence and machine learning techniques to generate actionable insights from vast quantities of data, making it the ideal analytics platform for these challenging programs. We are delighted to be working with NASA FDL’s other core technology partners to create meaningful solutions.”
About FD and Kx:
FD is a global technology provider with 20 years of experience working with some of the world’s largest finance, technology and energy institutions and employs over 1,700 people worldwide. The Group’s Kx technology is a leader in high-performance, in-memory computing, streaming analytics and operational intelligence. It delivers the best possible performance and flexibility for high-volume, data-intensive analytics and applications for multiple industries including for earth observation analytics, finance, pharmaceuticals and manufacturing.
For more information about FD: www.firstderivatives.com .
For more information about Kx please visit www.kx.com . For general inquiries, write to info@kx.com .
About FDL:
FDL is an applied artificial intelligence research accelerator and public / private partnership between NASA Ames Research Center and the SETI Institute. The program tackles knowledge gaps in space science by pairing machine learning expertise with astronomy and planetary science expertise at the PhD level. Interdisciplinary teams address tightly defined problems and the format encourages rapid iteration and prototyping to create outputs with meaningful application to the space program. FDL features partnerships with technology leaders in artificial intelligence from the private sector and academia. Partners bring advanced hardware, software and cloud-based resources, and provide coaching to research participants. Entering its second year, FDL strives to create research outcomes that support NASA research objectives, while simultaneously showcasing cutting-edge partner capabilities in deep learning and other machine learning approaches.
About the SETI Institute:
The mission of the SETI Institute is to explore, understand, and explain the origin and nature of life in the universe and to apply the knowledge gained to inspire and guide present and future generations,” said Bill Diamond, President and CEO of SETI Institute. “Education is an important part of that mission. Our programs share the excitement of exploration, the joy of discovery, and wonders of the universe with children, educators, and adults.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170622005415/en/
Contact:
For Kx Systems
Micky Izelaar
020 3837 3687
kxSystems@octopusgrp.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 18:00:00 CEST | Press release
- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with cystic fibrosis - - Oral presentation on new post hoc data from randomized, controlled and open-label trials suggest improved quality of life results with ALYFTREK compared to TRIKAFTA® – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conferenc
Andersen Consulting tilføjer dimension med David and Golyat6.6.2025 16:33:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin globale konsulentkapacitet gennem en samarbejdsaftale med David and Golyat, en filippinsk konsulentvirksomhed inden for digital strategi. Med et stærkt fokus på business intelligence, kundeindsigt og digital first-eksekvering arbejder David and Golyat med kunder på tværs af flere sektorer – herunder regeringer, udviklingsorganisationer og private virksomheder – for at skabe langsigtet værdi gennem datainformerede beslutninger. Miko David, administrerende partner i David and Golyat, siger: "Vi ser frem til samarbejdet med Andersen Consulting, da det er en milepæl i vores vækstforløb. Ved at kombinere vores ekspertise inden for digital strategi og Andersen Consultings globale platform er vi i stand til at levere endnu større værdi til kunder, der navigerer på komplekse markeder." "Dette samarbejde betyder, at vi kan tilføre en ekstra dimension til vores globale konsulentplatform," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktø
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology6.6.2025 16:00:00 CEST | Press release
IBSA Derma, the dermoaesthetic division of Swiss company IBSA, will participate in the 18th IMCAS Asia Congress in Bangkok, gathering over 3,000 professionals from across the region to explore the future of aesthetic and regenerative medicine.With the presence in the Congress and a dedicated scientific symposium, the company reaffirms its commitment to advancing bioremodeling approaches and promoting a holistic, science-driven vision of authentic beauty.This year marks a key milestone for IBSA Derma: 10 years of NAHYCO® Technology, a patented innovation in hyaluronic acid science that continues to shape the future of tissue regeneration. IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 14:00:00 CEST | Press release
Pivotal Study Advances to Establish Histotripsy as a Non-Thermal, Surgery-Free Alternative to Destroy and Liquefy Kidney Tumors HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison
Norwegian Tech Firm Builds Military Command Center in 24 Hours6.6.2025 13:45:00 CEST | Press release
Norwegian technology provider Cyviz has successfully developed a fully mobile and ballistic-proof command center - designed, configured, and made operational in just 24 hours. The solution was showcased during a military exercise led by the Dutch Ministry of Defence and has already sparked interest from NATO members and civil protection agencies across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606640770/en/ Cyviz demonstrates rapid deployment capability with a mobile, container-based control room for defense and crisis response Cyviz and its partners constructed the command room inside a 14-ton container designed for transport on standard military vehicles and resistant to machine gun fire. The unit was deployed at a military base in the Netherlands, where Cyviz was tasked with delivering a fully functional command-and-control environment, under strict time constraints and in a high-stakes simulation. "You do
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom